Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_16689 | 406 | 8.45 | Mlig455_057134 | Neo: - Age: - Region-enriched R7: 3.135/0.00000 Regeneration-downregulated BL: -3.116 Regeneration-depleted BL: -3.116 |
Mlig455_057134 {REF} {Length: 2836} {RNA1509_22940} {RNA1310_37294, RNA1509_22940} {RNA1509_22940, RNA815_33151} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -0.314 | 3.393 | 0.84132 | 1.00000 | |
RegionR2 | 1.134 | 3.393 | 0.05550 | 0.28248 | |
RegionR3 | -1.398 | 3.393 | 0.01756 | 0.21843 | |
RegionR4 | -2.785 | 3.393 | 0.00006 | 0.00106 | |
RegionR5 | -2.29 | 3.393 | 0.00015 | 0.00226 | |
RegionR6 | 1.447 | 3.393 | 0.00106 | 0.04004 | |
RegionR7 | 3.135 | 3.393 | 0.00000 | 0.00000 | |
RegionR8 | 1.071 | 3.393 | 0.18686 | 0.77571 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -5.785 | 3.393 | 0.27597 | 0.97768 | |
RegenerationR2 | 0.186 | 3.393 | 0.69936 | 0.95613 | |
RegenerationR3 | 1.504 | 3.393 | 0.01960 | 0.25606 | |
RegenerationR4 | 0.786 | 3.393 | 0.25385 | 0.70194 | |
RegenerationR5 | 0.749 | 3.393 | 0.23625 | 0.66992 | |
RegenerationR6 | 0.162 | 3.393 | 0.75180 | 0.95320 | |
RegenerationBL | -3.116 | 3.393 | 0.00021 | 0.00773 | Specific for BL: -3.116 |
RegenerationTP | -0.511 | 3.393 | 0.42560 | 0.84887 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_16689 | 406 | 8.45 | Mlig455_057134 | Neo: - Age: - Region-enriched R7: 3.135/0.00000 Regeneration-downregulated BL: -3.116 Regeneration-depleted BL: -3.116 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_057134 {REF} {Length: 2836} {RNA1509_22940} {RNA1310_37294, RNA1509_22940} {RNA1509_22940, RNA815_33151} | |
2. | MligTC455_30046 | 464 | 9.68 | Mlig455_000635 | Neo: - Age: - Region-enriched R7: 3.850/0.00000 |
LTBP2 | 2.635 | - | 0.775 | 0.961 | - | - | 0.899 | Mlig455_000635 {REF} {Length: 6232} {Pfam: Calcium-binding EGF domain [PF07645.17, score=81.0]; Complement Clr-like EGF-like [PF12662.9, score=35.4]; EGF-like domain [PF00008.29, score=19.4]; EGF domain [PF12947.9, score=18.7]} {Human: ENSG00000119681, LTBP2, latent transforming growth factor beta binding protein 2, [Score=130, Expect=2e-29]} {Mouse: ENSMUSG00000002020, Ltbp2, latent transforming growth factor beta binding protein 2, [Score=124, Expect=9e-28]} {Dmel: FBgn0035798, frac, faulty attraction, [Score=99.8, Expect=2e-20]} {Celegans: WBGene00003497, mup-4, Transmembrane matrix receptor MUP-4, [Score=98.6, Expect=3e-20]} {Smed: dd_Smed_v6_2649_0_1, dd_Smed_v6_2649_0_1, [Score=107, Expect=6e-23]} {RNA1509_5079} {RNA1310_710} {RNA815_417} |
3. | MligTC455_50732 | 650 | 13.55 | Mlig455_038869 | Neo: - Age: - Region-enriched R7: 3.648/0.00002 |
2.496 | - | 0.722 | 0.817 | - | - | 0.957 | Mlig455_038869 {REF} {Length: 922} {Dmel: FBgn0014024, Rnp4F, RNA-binding protein 4F, [Score=42.7, Expect=4e-06]} {RNA1509_37017} {RNA1310_48092.1, RNA1509_37017} {RNA1509_37017, RNA815_23660} | |
4. | MligTC455_25446 | 1416 | 29.51 | Mlig455_026922, Mlig455_027015, Mlig455_027079 | Neo: - Age: Up-Down-Up |
CPA2 | 2.41 | 0.724 | - | 0.708 | - | 0.978 | - | Mlig455_026922 {REF} {Length: 2528} {Pfam: Zinc carboxypeptidase [PF00246.26, score=234.4]} {Human: ENSG00000158516, CPA2, carboxypeptidase A2, [Score=197, Expect=3e-57]} {Mouse: ENSMUSG00000029788, Cpa5, carboxypeptidase A5, [Score=185, Expect=6e-53]; ENSMUSG00000071553, Cpa2, carboxypeptidase A2, pancreatic, [Score=184, Expect=2e-52]; ENSMUSG00000042501, Cpa6, carboxypeptidase A6, [Score=179, Expect=2e-50]; ENSMUSG00000021999, Cpb2, carboxypeptidase B2 (plasma), [Score=179, Expect=8e-51]} {Dmel: FBgn0029807, CG3108, [Score=211, Expect=3e-59]} {Celegans: WBGene00020281, T06A4.1, [RH, Score=229, Expect=4e-68]} {Smed: dd_Smed_v6_2282_0_1, dd_Smed_v6_2282_0_1, [RH, Score=243, Expect=2e-75]} {RNA1509_10385} {RNA1310_16293, RNA1509_10385} {RNA1509_10385, RNA815_6920} Mlig455_027015 {REF} {Length: 2531} {Pfam: Zinc carboxypeptidase [PF00246.26, score=237.0]} {Human: ENSG00000158516, CPA2, carboxypeptidase A2, [Score=201, Expect=5e-59]} {Mouse: ENSMUSG00000029788, Cpa5, carboxypeptidase A5, [Score=186, Expect=5e-53]; ENSMUSG00000071553, Cpa2, carboxypeptidase A2, pancreatic, [Score=184, Expect=7e-53]; ENSMUSG00000042501, Cpa6, carboxypeptidase A6, [Score=180, Expect=5e-51]; ENSMUSG00000021999, Cpb2, carboxypeptidase B2 (plasma), [Score=179, Expect=6e-51]} {Dmel: FBgn0029807, CG3108, [Score=212, Expect=2e-59]} {Celegans: WBGene00020281, T06A4.1, [RH, Score=230, Expect=1e-68]} {Smed: dd_Smed_v6_2282_0_1, dd_Smed_v6_2282_0_1, [RH, Score=241, Expect=2e-74]} {RNA1509_10385} {RNA1310_16293} {RNA815_6920} Mlig455_027079 {REF} {Length: 2476} {Pfam: Zinc carboxypeptidase [PF00246.26, score=237.0]} {Human: ENSG00000158516, CPA2, carboxypeptidase A2, [Score=201, Expect=5e-59]} {Mouse: ENSMUSG00000029788, Cpa5, carboxypeptidase A5, [Score=186, Expect=5e-53]; ENSMUSG00000071553, Cpa2, carboxypeptidase A2, pancreatic, [Score=184, Expect=7e-53]; ENSMUSG00000042501, Cpa6, carboxypeptidase A6, [Score=180, Expect=5e-51]; ENSMUSG00000021999, Cpb2, carboxypeptidase B2 (plasma), [Score=179, Expect=6e-51]} {Dmel: FBgn0029807, CG3108, [Score=212, Expect=2e-59]} {Celegans: WBGene00020281, T06A4.1, [RH, Score=230, Expect=1e-68]} {Smed: dd_Smed_v6_2282_0_1, dd_Smed_v6_2282_0_1, [RH, Score=241, Expect=2e-74]} {RNA1509_10385} {RNA1310_16293} {RNA815_6920} |
5. | MligTC455_43747 | 186 | 3.88 | Mlig455_019998 | Neo: - Age: - Region-enriched R2: 3.849/0.00050 |
GLRA3 | 1.885 | - | - | - | 0.975 | 0.910 | - | Mlig455_019998 {REF} {Length: 2977} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=148.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=117.6]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [RH, Score=337, Expect=2e-111]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [RH, Score=332, Expect=1e-109]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [RH, Score=338, Expect=1e-111]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [RH, Score=330, Expect=5e-109]} {Dmel: FBgn0024963, GluClalpha, [RH, Score=292, Expect=2e-94]} {Celegans: WBGene00001586, ggr-1, Glycine receptor subunit beta-type 4, [RH, Score=260, Expect=1e-81]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=254, Expect=4e-80]} {RNA1509_22140} {RNA1310_19557.2} {RNA815_6481} |
6. | MligTC455_42887 | 60 | 1.24 | Mlig455_036468, Mlig455_056252 | Neo: - Age: - |
CCKAR | 1.854 | - | - | - | 0.887 | 0.967 | - | Mlig455_036468 {REF} {Length: 2390} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=81.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=37.9]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=19.5]} {Human: ENSG00000163394, CCKAR, cholecystokinin A receptor, [Score=53.5, Expect=5e-07]; ENSG00000170425, ADORA2B, adenosine A2b receptor, [Score=53.1, Expect=4e-07]} {Mouse: ENSMUSG00000026237, Nmur1, neuromedin U receptor 1, [Score=59.3, Expect=4e-09]} {Dmel: FBgn0264002, MsR2, Myosuppressin receptor 2, [Score=57.0, Expect=3e-08]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=68.6, Expect=3e-12]} {Smed: dd_Smed_v6_9550_0_1, dd_Smed_v6_9550_0_1, [Score=69.7, Expect=9e-13]} {RNA1310_37299} {RNA815_29990} Mlig455_056252 {REF} {Length: 2265} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.8]} {RNA1310_56612} {RNA815_44133} |
7. | MligTC455_50509 | 38 | 0.79 | Mlig455_024809 | Neo: - Age: - |
1.832 | - | - | 0.955 | - | 0.877 | - | Mlig455_024809 {REF} {Length: 2779} {RNA1310_44589} {RNA815_56600} | |
8. | MligTC455_51026 | 344 | 7.18 | Mlig455_067853 | Neo: - Age: Down-Up-Down |
1.768 | - | - | - | 0.811 | 0.957 | - | Mlig455_067853 {REF} {Length: 1286} {Smed: dd_Smed_v6_5153_0_1, dd_Smed_v6_5153_0_1, [Score=70.5, Expect=3e-15]} {RNA1509_26429} {RNA1310_8536} {RNA815_8992} | |
9. | MligTC455_45436 | 10799 | 224.98 | Mlig455_057495 | Neo: - Age: Down-Down-Up Region-enriched R8: 2.400/0.00013 |
1.685 | - | - | 0.954 | 0.731 | - | - | Mlig455_057495 {REF} {Length: 870} {RNA1509_3109} {RNA1310_74049} {RNA815_20278.2} | |
10. | MligTC455_40766 | 99 | 2.05 | Mlig455_012729 | Neo: - Age: Down-Down-Up |
TP53I11 | 1.678 | - | 0.721 | - | - | - | 0.957 | Mlig455_012729 {REF} {Length: 2823} {Pfam: Tumour protein p53-inducible protein 11 [PF14936.8, score=89.2]} {Human: ENSG00000175274, TP53I11, tumor protein p53 inducible protein 11, [Score=65.5, Expect=4e-13]} {Mouse: ENSMUSG00000068735, Trp53i11, transformation related protein 53 inducible protein 11, [Score=66.6, Expect=2e-13]} {Celegans: WBGene00021185, Y9C12A.1, [Score=67.0, Expect=2e-13]} {RNA1310_38478} {RNA815_33223} |
11. | MligTC455_23101 | 397 | 8.28 | Mlig455_048080 | Neo: - Age: - Region-enriched R2: 3.122/0.00807 |
1.667 | - | - | - | - | 0.712 | 0.955 | Mlig455_048080 {REF} {Length: 721} {TRANSSPLICED} {RNA1509_16955} {RNA1310_49452, RNA1509_16955} {RNA1509_16955, RNA815_4585} | |
12. | MligTC455_21038 | 10 | 0.22 | Mlig455_026297, Mlig455_052713 | Neo: - Age: - |
GLRA2 | 0.97 | - | - | - | - | 0.970 | - | Mlig455_026297 {REF} {Length: 3375} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=137.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=102.8]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=259, Expect=5e-80]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=258, Expect=2e-79]; ENSG00000109738, GLRB, glycine receptor beta, [Score=257, Expect=1e-78]; ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=253, Expect=4e-78]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=249, Expect=5e-76]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=259, Expect=6e-80]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=253, Expect=3e-77]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=253, Expect=1e-77]; ENSMUSG00000028020, Glrb, glycine receptor, beta subunit, [Score=250, Expect=4e-76]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=8e-76]} {Dmel: FBgn0024963, GluClalpha, [Score=245, Expect=6e-75]} {Celegans: WBGene00001591, glc-1, Glutamate-gated chloride channel alpha, [Score=241, Expect=2e-73]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=280, Expect=1e-88]} {RNA1310_99355} Mlig455_052713 {REF} {Length: 1407} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=139.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=78.3]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=259, Expect=3e-82]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=253, Expect=5e-80]; ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=252, Expect=5e-80]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=249, Expect=2e-78]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=258, Expect=4e-82]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=253, Expect=5e-80]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=252, Expect=2e-79]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=2e-78]} {Dmel: FBgn0024963, GluClalpha, [Score=238, Expect=5e-76]} {Celegans: WBGene00001591, glc-1, Glutamate-gated chloride channel alpha, [Score=238, Expect=2e-74]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=275, Expect=4e-89]} {RNA1310_135132} |
13. | MligTC455_36989 | 51 | 1.07 | Mlig455_041718, Mlig455_042063 | Neo: - Age: - |
0.969 | - | - | - | - | 0.969 | - | Mlig455_041718 {REF} {Length: 1828} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=36.1]; TgpA N-terminal domain [PF11992.10, score=18.4]} {Smed: dd_Smed_v6_24483_0_1, dd_Smed_v6_24483_0_1, [RH, Score=139, Expect=7e-37]} {RNA1310_21197} {RNA815_30263} Mlig455_042063 {REF} {Length: 1786} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=36.1]; TgpA N-terminal domain [PF11992.10, score=18.4]} {Smed: dd_Smed_v6_24483_0_1, dd_Smed_v6_24483_0_1, [RH, Score=139, Expect=7e-37]} {RNA1310_21197} {RNA815_30263} |
|
14. | MligTC455_12687 | 7 | 0.15 | Mlig455_016746, Mlig455_016758 | Neo: - Age: Up-Down-Up |
CACNA1C, CACNA1D | 0.968 | - | - | - | - | 0.968 | - | Mlig455_016746 {REF} {Length: 8806} {Pfam: Ion transport protein [PF00520.33, score=816.5]; Voltage gated calcium channel IQ domain [PF08763.13, score=101.9]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=91.0]; Polycystin cation channel [PF08016.14, score=23.2]; Protein trafficking PGA2 [PF07543.14, score=19.7]} {Human: ENSG00000285479, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [RH, Score=1801, Expect=0.0]; ENSG00000151067, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [RH, Score=1801, Expect=0.0]; ENSG00000157388, CACNA1D, calcium voltage-gated channel subunit alpha1 D, [RH, Score=1757, Expect=0.0]; ENSG00000081248, CACNA1S, calcium voltage-gated channel subunit alpha1 S, [RH, Score=1723, Expect=0.0]} {Mouse: ENSMUSG00000051331, Cacna1c, calcium channel, voltage-dependent, L type, alpha 1C subunit, [RH, Score=1806, Expect=0.0]; ENSMUSG00000015968, Cacna1d, calcium channel, voltage-dependent, L type, alpha 1D subunit, [RH, Score=1753, Expect=0.0]; ENSMUSG00000026407, Cacna1s, calcium channel, voltage-dependent, L type, alpha 1S subunit, [RH, Score=1718, Expect=0.0]} {Dmel: FBgn0001991, Ca-alpha1D, Ca[2+]-channel protein alpha[[1]] subunit D, [RH, Score=1899, Expect=0.0]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [RH, Score=1809, Expect=0.0]} {Smed: dd_Smed_v6_8899_0_27, dd_Smed_v6_8899_0_27, [RH, Score=1934, Expect=0.0]} {RNA1509_7565} {RNA1310_546.1} {RNA815_3074} Mlig455_016758 {REF} {Length: 716} {Human: ENSG00000157388, CACNA1D, calcium voltage-gated channel subunit alpha1 D, [Score=52.4, Expect=3e-07]} {Mouse: ENSMUSG00000015968, Cacna1d, calcium channel, voltage-dependent, L type, alpha 1D subunit, [Score=50.1, Expect=1e-06]} {RNA1509_7565} {RNA1310_1492.2} {RNA815_11990} |
15. | MligTC455_41169 | 31 | 0.65 | Mlig455_047881 | Neo: - Age: - |
0.958 | - | - | 0.958 | - | - | - | Mlig455_047881 {REF} {Length: 686} {NoTransDecoderORF} {RNA1310_34768.1} | |
16. | MligTC455_09723 | 43 | 0.89 | Mlig455_048052, Mlig455_048071 | Neo: - Age: Up-Down-Down |
0.956 | - | - | - | - | 0.956 | - | Mlig455_048052 {REF} {Length: 3592} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=110.8]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=57.6]; Glycine rich protein family [PF07172.13, score=21.2]} {Dmel: FBgn0033579, CG13229, [Score=121, Expect=1e-29]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=135, Expect=2e-34]} {Smed: dd_Smed_v6_24203_0_1, dd_Smed_v6_24203_0_1, [Score=204, Expect=1e-60]} {RNA1509_18576} {RNA1310_81440} {RNA815_16348} Mlig455_048071 {REF} {Length: 4002} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=110.0]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=58.2]; Glycine rich protein family [PF07172.13, score=21.9]} {Dmel: FBgn0033579, CG13229, [Score=119, Expect=5e-29]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=131, Expect=4e-33]} {Smed: dd_Smed_v6_24203_0_1, dd_Smed_v6_24203_0_1, [Score=202, Expect=8e-60]} {RNA1509_18576} {RNA1310_81440} {RNA815_16348} |
|
17. | MligTC455_42010 | 89 | 1.85 | Mlig455_040323 | Neo: - Age: Up-Down-Down |
SEC23IP | 0.956 | - | - | - | - | 0.956 | - | Mlig455_040323 {REF} {Length: 3149} {TRANSSPLICED} {Pfam: DDHD domain [PF02862.19, score=163.9]; SAM domain (Sterile alpha motif) [PF00536.32, score=29.1]; SAM domain (Sterile alpha motif) [PF07647.19, score=21.0]; WWE domain [PF02825.22, score=20.1]} {Human: ENSG00000107651, SEC23IP, SEC23 interacting protein, [RH, Score=489, Expect=7e-159]; ENSG00000085788, DDHD2, DDHD domain containing 2, [RH, Score=476, Expect=2e-157]} {Mouse: ENSMUSG00000055319, Sec23ip, Sec23 interacting protein, [RH, Score=492, Expect=2e-160]; ENSMUSG00000061313, Ddhd2, DDHD domain containing 2, [RH, Score=470, Expect=2e-155]} {Dmel: FBgn0031990, PAPLA1, Phosphatidic Acid Phospholipase A1, [RH, Score=258, Expect=2e-75]} {Celegans: WBGene00019747, ipla-1, Intracelllar PhosphoLipase A family; Intracellular phospholipase A1, [Score=97.4, Expect=1e-20]} {Smed: dd_Smed_v6_4014_0_1, dd_Smed_v6_4014_0_1, [RH, Score=287, Expect=9e-83]} {RNA1509_38825} {RNA1310_9070.1} {RNA815_7099} |
18. | MligTC455_12729 | 17 | 0.35 | Mlig455_059868 | Neo: - Age: - |
0.955 | - | - | - | - | 0.955 | - | Mlig455_059868 {REF} {Length: 655} {NoTransDecoderORF} {RNA1509_32319} {RNA1310_13107.1} {RNA815_39540} | |
19. | MligTC455_25169 | 62 | 1.29 | Mlig455_017959 | Neo: Irradiation Age: - |
SPECC1L | 0.954 | - | - | 0.954 | - | - | - | Mlig455_017959 {REF} {Length: 4845} {TRANSSPLICED} {Pfam: Calponin homology (CH) domain [PF00307.33, score=68.3]; CAMSAP CH domain [PF11971.10, score=22.3]} {Human: ENSG00000100014, SPECC1L, sperm antigen with calponin homology and coiled-coil domains 1 like, [RH, Score=264, Expect=5e-73]} {Mouse: ENSMUSG00000033444, Specc1l, sperm antigen with calponin homology and coiled-coil domains 1-like, [RH, Score=261, Expect=3e-72]} {Dmel: FBgn0025633, CG13366, [RH, Score=187, Expect=3e-48]} {Celegans: WBGene00020530, T15B12.1, [Score=128, Expect=3e-31]} {Smed: dd_Smed_v6_7845_0_1, dd_Smed_v6_7845_0_1, [Score=159, Expect=7e-40]} {RNA1509_39130, RNA1509_7795} {RNA1310_10182.1, RNA1509_39130, RNA1509_7795} {RNA1509_39130, RNA1509_7795, RNA815_11375} |
20. | MligTC455_36604 | 20 | 0.43 | Mlig455_025571 | Neo: - Age: - |
0.952 | - | - | - | - | 0.952 | - | Mlig455_025571 {REF} {Length: 1241} {NoTransDecoderORF} {RNA1509_47691} {RNA1310_134162} {RNA815_32338} | |
21. | MligTC455_20111 | 14 | 0.29 | Mlig455_028941 | Neo: - Age: - |
IGSF9 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_028941 {REF} {Length: 3748} {Pfam: Immunoglobulin domain [PF13927.8, score=128.9]; Immunoglobulin I-set domain [PF07679.18, score=93.2]; Immunoglobulin domain [PF13895.8, score=81.2]; Immunoglobulin domain [PF00047.27, score=74.0]; Immunoglobulin V-set domain [PF07686.19, score=70.7]; Fibronectin type III domain [PF00041.23, score=38.4]; Izumo-like Immunoglobulin domain [PF16706.7, score=26.6]; Immunoglobulin domain [PF18452.3, score=21.2]} {Human: ENSG00000085552, IGSF9, immunoglobulin superfamily member 9, [Score=149, Expect=1e-35]} {Mouse: ENSMUSG00000037995, Igsf9, immunoglobulin superfamily, member 9, [Score=149, Expect=6e-36]; ENSMUSG00000034275, Igsf9b, immunoglobulin superfamily, member 9B, [Score=145, Expect=8e-35]} {Dmel: FBgn0028482, bdl, borderless, [Score=125, Expect=6e-29]} {Celegans: WBGene00020130, igcm-2, ImmunoGlobulin-like Cell adhesion Molecule family, [Score=137, Expect=6e-33]} {Smed: dd_Smed_v6_17743_0_1, dd_Smed_v6_17743_0_1, [Score=140, Expect=9e-34]} {RNA1310_20896} {RNA815_28649} |
22. | MligTC455_39879 | 172 | 3.58 | Mlig455_034586 | Neo: - Age: - |
0.951 | - | - | - | - | - | 0.951 | Mlig455_034586 {REF} {Length: 4363} {Pfam: Innexin [PF00876.20, score=329.2]} {Dmel: FBgn0027108, Inx2, Innexin 2, [Score=115, Expect=8e-29]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=248, Expect=3e-79]} {Smed: dd_Smed_v6_10567_0_1, dd_Smed_v6_10567_0_1, [Score=462, Expect=4e-163]} {RNA1509_13614} {RNA1310_25662} {RNA815_11362} | |
23. | MligTC455_26118 | 25 | 0.52 | Mlig455_036932 | Neo: - Age: logFC(26M/2M)=0.870 |
0.95 | - | - | - | - | 0.950 | - | Mlig455_036932 {REF} {Length: 2939} {RNA1509_28486} {RNA1310_24343.1} {RNA815_8096} |